Global Powered Surgical Instrument Market will generate $2,731 million by 2025

By -
According to a new report published by Allied Market Research, titled,"Powered Surgical Instrument Market by Product, Power Source, and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global powered surgical instrument market generated $1,943 million in 2017 and is projected to reach $2,731 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. The handpieces segment accounted for more than three-fifth of the total market share in 2017.
Powered surgical instruments are high-powered specially designed instruments that are used for performing specific or desired actions during a surgery. There are several high-powered surgical drill systems present in the market such as reamer systems, saw systems, stapler, shavers, and other handpieces, which are used during orthopedic, neuro, cardiovascular, cardiothoracic, and various other surgeries.
The global powered surgical instrument market is expected to exhibit significant growth during the forecast period due to increasing prevalence of chronic diseases globally and growing aging population. In addition, increasing volume of surgical procedures further supplements the growth of the global market. However, pressure of reducing healthcare cost and lack of skilled personnel in the developing countries are projected to impede the market growth. On the contrary, growing medical tourism in developing countries is expected to provide lucrative opportunities for the market growth.
Based on product, the market is segmented into handpieces, power source & controls, and accessories. Handpieces segment is further divided into drill systems, reamer systems, saw systems, stapler, shavers, and others. Power source & controls segment is further divided into batteries, electric consoles, and pneumatic regulators. Accessories segment is further divided into surgical accessories and electrical accessories. The accessories segment is anticipated to exhibit the highest CAGR during forecast period due to bulk purchase, low cost, and shorter lifespan than the product.
By application, the market is classified into orthopedic surgery, neurosurgery, ENT surgery, cardiovascular surgery, plastic surgery, cardiothoracic surgery, and others. The orthopedic surgery segment was the major revenue contributor in 2017 and is projected to continue this trend during the forecast period, due to the rising demand of minimally invasive surgery in orthopedics and growing aging population which in turn increases the demand of powered surgical instruments in orthopedic surgery.
North America is expected to remain dominant throughout the forecast period due to the highly sophisticated healthcare infrastructure and high adoption rate of technologically advanced surgical tools. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly due to growing medical tourism in this region.

Key Findings of thePowered Surgical Instrument Market:

  • Based on power source, the battery-powered instruments segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 4.9% from 2018 to 2025.
  • Depending on application, the cardiovascular surgery segment is expected to exhibit the highest CAGR during the forecast period.
  • By product, the handpieces segment was the major revenue contributor in 2017 and is anticipated to continue this trend during the forecast period.
  • The U.S. generated the highest revenue in the global powered surgical instrument market in 2017, accounting for almost two-fifth of the global market in 2017.
  • Asia-Pacific is estimated to grow at a CAGR of 5.4% during the forecast period.
The report provides a comprehensive analysis of the key players operating in the global powered surgical instrument market, namely, AlloTech Co. Ltd., Conmed Corporation, Depuy Synthes (Johnson & Johnson), Medtronic plc, Stryker Corporation, Zimmer Biomet, adeor Medical AG, Smith & Nephew plc, B. Braun Melsungen AG, and MicroAire Surgical Instruments, LLC.
The other players in the value chain include De Soutter Medical Ltd., GEISTER Medizintechnik GmbH, Peter Brasseler Holdings, LLC, Ruijin Medical Instrument & Device Co., Ltd., Intrauma S.p.A., and others.

Comments

Post a Comment

Popular posts from this blog

Doctors recommend for blood gas test if symptoms such as shortness of breath, difficulty in breathing, confusion

By -
Image
Blood gas analyzers  are used to measure different parameters such as pH, blood gas such as pCO2 and pO2, electrolytes, and metabolites from the whole blood sample.  Blood  is collected from the patient and introduced into the analyzer. The analyzer leads the blood into a measuring chamber, which has ion selective electrodes (IE), the electrodes that are sensitive only to the measurement of interest. This analysis of the blood sample helps to detect medical conditions such as kidney failure, heart failure, uncontrolled diabetes, hemorrhage, chemical poisoning, a drug overdose, shock, asthma, and chronic obstructive pulmonary disease (COPD). Doctors recommend for blood gas test if symptoms such as shortness of breath, difficulty in breathing, confusion, and nausea are witnessed. Global Blood Gas and Electrolyte Analyzers Market accounted for $1,427 million in 2016, and is anticipated to reach $2,104 million by 2023, registering a CAGR of 5.7%. In terms of volume, the global volume marke
Read more

The global specialty enzymes market is expected to register a CAGR of 9.4% during 2021-2028

By -
Image
The global   specialty enzymes market   is expected to register a CAGR of 9.4% during 2015-2020. The pharmaceuticals application segment accounted for about half of the overall market share in 2014. The Asia Pacific market would exhibit the highest CAGR of 11.7% during the forecast period (2015-2020). Specialty enzymes are proteins that act as biocatalysts to accelerate chemical reaction and produce the desired results. Owing to low consumption and high degree of specificity, specialty enzymes are witnessing spurring demand in medical applications such as pharmaceutical, biotechnology research and diagnostics. The growing popularity of specialty enzymes in therapies for chronic diseases such as cancer, cardiovascular diseases, pain and inflammatory disorders among others is the vital force fuelling the market growth. In addition, growing awareness about enzyme-based therapeutics in the Asia Pacific and LAMEA region would further boost the market growth. However, safety concerns due to
Read more